Soltis Investment Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$987K Buy
11,579
+552
+5% +$49.2K 0.06% 223
2025
Q4
$871K Buy
11,027
+373
+4% +$29.2K 0.06% 228
2025
Q3
$852K Sell
10,654
-370
-3% -$31.6K 0.06% 222
2025
Q2
$1M Buy
11,024
+546
+5% +$49.8K 0.08% 172
2025
Q1
$982K Sell
10,478
-267
-2% -$23.9K 0.09% 171
2024
Q4
$977K Buy
10,745
+8,480
+374% +$809K 0.09% 165
2024
Q3
$235K Buy
+2,265
New +$231K 0.02% 323

Other funds holding CL

Soltis Investment Advisors's CL Position: Q1 2026 in Review

Soltis Investment Advisors increased its Colgate-Palmolive (CL) stake by 5% in Q1 2026, buying an estimated $49.2K and bringing the position to 11,579 shares worth $987K. The position accounts for 0.06% of the portfolio, ranked #223.

Soltis Investment Advisors first reported a position in CL in Q3 2024 and has held it in 7 quarters since. The position peaked at $1M in Q2 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Soltis Investment Advisors held 11,579 shares of Colgate-Palmolive worth $987K as of Q1 2026.
  • Soltis Investment Advisors bought 552 Colgate-Palmolive shares in Q1 2026, an estimated $49.2K.
  • Colgate-Palmolive made up 0.06% of Soltis Investment Advisors's portfolio in Q1 2026, its #223 holding.
  • Soltis Investment Advisors first reported a position in Colgate-Palmolive in Q3 2024 and has held it in 7 quarters since.
  • Soltis Investment Advisors's Colgate-Palmolive position peaked at $1M in Q2 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Soltis Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.